Skip to main content
logo
Noveris Health Sciences Inc. (CSE:NVRS)
Canada flag Canada · Delayed Price · Currency is CAD
0.9200
-0.9700 (-51.32%)
May 1, 2026, 3:03 PM EST

Noveris Health Sciences Cash Flow Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
2.29-3.15-20.95-9.25-28.9-26.95
Depreciation & Amortization
--0.010.130.240.06
Loss (Gain) From Sale of Assets
-0.05-0.05----
Asset Writedown & Restructuring Costs
-----5.03
Loss (Gain) From Sale of Investments
--5.14---
Stock-Based Compensation
----3.22.49
Other Operating Activities
-0.410.85-6.85.5510.43
Change in Accounts Receivable
0.05-0.09-0.08-0-
Change in Accounts Payable
-2.032.153.214.70.71.87
Change in Other Net Operating Assets
0.140.2123.31-5.29-0.09
Operating Cash Flow
-0.01-0.04-4.22-8.43-24.05-7.12
Capital Expenditures
-----0.29-0.29
Cash Acquisitions
-----0.5
Sale (Purchase) of Intangibles
------0.11
Investment in Securities
--0.53--0.07-0.31
Other Investing Activities
----0.04-0.11-0.37
Investing Cash Flow
--0.53-0.04-0.47-0.57
Short-Term Debt Issued
--0.110.18--
Long-Term Debt Issued
----5.54.7
Total Debt Issued
--0.110.185.54.7
Short-Term Debt Repaid
----0.1--
Long-Term Debt Repaid
------0.1
Total Debt Repaid
----0.1--0.1
Net Debt Issued (Repaid)
--0.110.075.54.6
Issuance of Common Stock
--3.617.5721.015.68
Other Financing Activities
----0.66-2.68-0.36
Financing Cash Flow
--3.726.9823.839.92
Foreign Exchange Rate Adjustments
------0.05
Net Cash Flow
-0.01-0.040.03-1.48-0.72.17
Free Cash Flow
-0.01-0.04-4.22-8.43-24.34-7.42
Free Cash Flow Margin
-----324889.79%-283414.75%
Free Cash Flow Per Share
-0.01-0.03-6.87-48.73-259.99-163.06
Levered Free Cash Flow
-2.09-0.94-4.3-5.33-14.3-2.09
Unlevered Free Cash Flow
-1.76-0.04-3.48-4.76-14.17-2.08
Change in Working Capital
-1.842.365.37.93-4.591.79
Source: S&P Global Market Intelligence. Standard template. Financial Sources.